Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

597 ARTÍCULOS , VIENDO DEL 466 AL 480

Targeted Interdisciplinary Model for Evaluation and Treatment of Neuropsychiatric Symptoms: A Cluster Randomized Controlled Trial

Lichtwarck B, Selbaek G, Kirkevold Ø, Rokstad AMM, Benth JŠ, Lindstrøm JC, Bergh S.

Am J Geriatr Psychiatry. 2018 Jan;26(1):25-38. doi: 10.1016/j.jagp.2017.05.015. Epub 2017 Jun 1.

Prevention of cognitive impairment: scientific guidance and windows of opportunity

Gorelick PB.

J Neurochem. 2018 Mar;144(5):609-616. doi: 10.1111/jnc.14113. Epub 2017 Aug 16.

A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease

Croteau E, Castellano CA, Fortier M, Bocti C, Fulop T, Paquet N, Cunnane SC.

Exp Gerontol. 2018 Jul 1;107:18-26. doi: 10.1016/j.exger.2017.07.004. Epub 2017 Jul 12.

Neuropsychological tools to predict conversion from amnestic mild cognitive impairment to dementia. The TREDEM Registry

Gallucci M, Di Battista ME, Battistella G, Falcone C, Bisiacchi PS, Di Giorgi E.

Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2018 Jul;25(4):550-560. doi: 10.1080/13825585.2017.1349869. Epub 2017 Jul 18.

Rho-associated protein kinases as therapeutic targets for both vascular and parenchymal pathologies in Alzheimer's disease

Lai AY, McLaurin J.

J Neurochem. 2018 Mar;144(5):659-668. doi: 10.1111/jnc.14130. Epub 2017 Aug 29.

A randomized controlled trial of disclosing genetic risk information for Alzheimer disease via telephone

Christensen KD, Uhlmann WR, Roberts JS, Linnenbringer E, Whitehouse PJ, Royal CDM, Obisesan TO, Cupples LA, Butson MB, Fasaye GA, Hiraki S, Chen CA, Siebert U, Cook-Deegan R, Green RC.

Genet Med. 2018 Jan;20(1):132-141. doi: 10.1038/gim.2017.103. Epub 2017 Jul 20.

Dementia risk and prevention by targeting modifiable vascular risk factors

Tariq S, Barber PA.

J Neurochem. 2018 Mar;144(5):565-581. doi: 10.1111/jnc.14132. Epub 2017 Sep 6.

Adaptation and validation into Portuguese language of the six-item cognitive impairment test (6CIT)

Apóstolo JLA, Paiva DDS, Silva RCGD, Santos EJFD, Schultz TJ.

Aging Ment Health. 2018 Sep;22(9):1184-1189. doi: 10.1080/13607863.2017.1348473. Epub 2017 Jul 25.

Changing clinical phenotypes of HIV-associated neurocognitive disorders

Sacktor N.

J Neurovirol. 2018 Apr;24(2):141-145. doi: 10.1007/s13365-017-0556-6. Epub 2017 Jul 27.

Measurement tools of resource use and quality of life in clinical trials for dementia or cognitive impairment interventions: A systematically conducted narrative review

Yang F, Dawes P, Leroi I, Gannon B.

Int J Geriatr Psychiatry. 2018 Feb;33(2):e166-e176. doi: 10.1002/gps.4771. Epub 2017 Aug 10.

PERK as a hub of multiple pathogenic pathways leading to memory deficits and neurodegeneration in Alzheimer's disease

Ohno M.

Brain Res Bull. 2018 Jul;141:72-78. doi: 10.1016/j.brainresbull.2017.08.007. Epub 2017 Aug 10.

Humanized mice: models for evaluating NeuroHIV and cure strategies

Honeycutt JB, Garcia JV.

J Neurovirol. 2018 Apr;24(2):185-191. doi: 10.1007/s13365-017-0567-3. Epub 2017 Aug 22.

The role of exercise in mitigating subcortical ischemic vascular cognitive impairment

Dao E, Hsiung GR, Liu-Ambrose T.

J Neurochem. 2018 Mar;144(5):582-594. doi: 10.1111/jnc.14153. Epub 2017 Sep 27.

Cerebral amyloid angiopathy as a cause of neurodegeneration

Smith EE.

J Neurochem. 2018 Mar;144(5):651-658. doi: 10.1111/jnc.14157. Epub 2017 Sep 21.

Do low-serum vitamin E levels increase the risk of Alzheimer disease in older people? Evidence from a meta-analysis of case-control studies

Dong Y, Chen X, Liu Y, Shu Y, Chen T, Xu L, Li M, Guan X.

Int J Geriatr Psychiatry. 2018 Feb;33(2):e257-e263. doi: 10.1002/gps.4780. Epub 2017 Aug 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias